{"id":88135,"date":"2026-05-15T15:06:38","date_gmt":"2026-05-15T09:36:38","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=88135"},"modified":"2026-05-15T15:06:40","modified_gmt":"2026-05-15T09:36:40","slug":"valiant-laboratories-q4-fy26-results","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/valiant-laboratories-q4-fy26-results\/","title":{"rendered":"Valiant Laboratories Q4 FY26 Results: Announced May 14 2026 Specialty Pharma &#8211; API"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p><a href=\"https:\/\/univest.in\/user\/stocks\/valiantlab\/valiant-laboratories-ltd-share-price-today\">Valiant Laboratories<\/a> results were announced on May 14, 2026, at the company&#8217;s board meeting. Q4 FY26 PAT Rs 0.70 crore on revenue Rs 57.79 crore. Active Pharmaceutical Ingredient manufacturer focused on paracetamol and related analgesic compounds. Plant in Ankleshwar, Gujarat. API segment margins under pressure from lower realizations and competition. Recovery depends on new product launches and capacity utilisation improvement. Investors tracking the company will find complete financial data, analysis, and FY27 outlook in this article.<\/p>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Click Here \u2013 Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/valiant-laboratories-q4-fy26-results\/#Valiant_Laboratories_Q4_FY26_Key_Financial_Highlights\" title=\"Valiant Laboratories Q4 FY26 Key Financial Highlights\">Valiant Laboratories Q4 FY26 Key Financial Highlights<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/valiant-laboratories-q4-fy26-results\/#Valiant_Laboratories_Performance_Analysis\" title=\"Valiant Laboratories Performance Analysis\">Valiant Laboratories Performance Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/valiant-laboratories-q4-fy26-results\/#Valiant_Laboratories_FY27_Outlook\" title=\"Valiant Laboratories FY27 Outlook\">Valiant Laboratories FY27 Outlook<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/valiant-laboratories-q4-fy26-results\/#Frequently_Asked_Questions_on_Valiant_Laboratories_Q4_FY26_Results\" title=\"Frequently Asked Questions on Valiant Laboratories Q4 FY26 Results\">Frequently Asked Questions on Valiant Laboratories Q4 FY26 Results<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/valiant-laboratories-q4-fy26-results\/#What_is_Valiant_Laboratories_Q4_FY26_PAT\" title=\"What is Valiant Laboratories Q4 FY26 PAT?\">What is Valiant Laboratories Q4 FY26 PAT?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/valiant-laboratories-q4-fy26-results\/#When_did_Valiant_Laboratories_announce_Q4_FY26_results\" title=\"When did Valiant Laboratories announce Q4 FY26 results?\">When did Valiant Laboratories announce Q4 FY26 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/valiant-laboratories-q4-fy26-results\/#What_is_the_FY27_outlook_for_Valiant_Laboratories\" title=\"What is the FY27 outlook for Valiant Laboratories?\">What is the FY27 outlook for Valiant Laboratories?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/valiant-laboratories-q4-fy26-results\/#Where_can_I_track_Valiant_Laboratories_Q4_FY26_live_data\" title=\"Where can I track Valiant Laboratories Q4 FY26 live data?\">Where can I track Valiant Laboratories Q4 FY26 live data?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Valiant_Laboratories_Q4_FY26_Key_Financial_Highlights\"><\/span><strong>Valiant Laboratories Q4 FY26 Key Financial Highlights<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<tbody>\n<tr>\n<th><strong>Metric<\/strong><\/th>\n<th><strong>Q4 FY26<\/strong><\/th>\n<th><strong>Comparison<\/strong><\/th>\n<\/tr>\n<tr>\n<td><strong>PAT (Net Profit)<\/strong><\/td>\n<td>Rs 0.70 crore<\/td>\n<td>Q4 FY26<\/td>\n<\/tr>\n<tr>\n<td><strong>Revenue from Operations<\/strong><\/td>\n<td>Rs 58 crore<\/td>\n<td>Q4 FY26<\/td>\n<\/tr>\n<tr>\n<td><strong>Ticker<\/strong><\/td>\n<td>VALIANTLAB<\/td>\n<td>Sector: Specialty Pharma &#8211; API<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><a href=\"https:\/\/univest.in\/screeners\"><strong>Screen the best stocks on the Univest Screener.<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Valiant_Laboratories_Performance_Analysis\"><\/span><strong>Valiant Laboratories Performance Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The company results reflect the company&#8217;s operational performance during the January to March 2026 quarter. the company results announced May 14, 2026. The company manufactures active pharmaceutical ingredients (APIs) for the domestic and export markets. Investors and analysts monitoring the company results will focus on FY27 revenue guidance, margin trajectory, and management commentary on business outlook.<\/p>\n<p>The company performance positions the company for FY27. Track the company analyst ratings and live stock price on the Univest Screener for real-time investment insights.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Valiant_Laboratories_FY27_Outlook\"><\/span><strong>Valiant Laboratories FY27 Outlook<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Post <strong>Valiant<\/strong>, investor focus for FY27 will be on revenue growth momentum, margin expansion, new order wins, and sector-specific tailwinds in the Specialty Pharma &#8211; API space. The <strong>Valiant<\/strong> results demonstrate the company&#8217;s execution capabilities. Track <strong>Valiant<\/strong> updates on the Univest Screener for analyst views and FY27 earnings estimates.<\/p>\n<p>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or the <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track live price and Q4 FY26 earnings updates.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Valiant_Laboratories_Q4_FY26_Results\"><\/span><strong>Frequently Asked Questions on Valiant Laboratories Q4 FY26 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Valiant_Laboratories_Q4_FY26_PAT\"><\/span><strong>What is Valiant Laboratories Q4 FY26 PAT?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> <strong>Valiant Laboratories Q4 FY26<\/strong> PAT of Rs 0.70 crore (results declared May 14, 2026). Q4 FY26 PAT Rs 0.70 crore on revenue Rs 57.79 crore. Active Pharmaceutical Ingredient manufacturer focused on paracetamol and related analgesic compou.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"When_did_Valiant_Laboratories_announce_Q4_FY26_results\"><\/span><strong>When did Valiant Laboratories announce Q4 FY26 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> the company results were announced on May 14, 2026, at the company&#8217;s board meeting and filed with BSE and NSE.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_FY27_outlook_for_Valiant_Laboratories\"><\/span><strong>What is the FY27 outlook for Valiant Laboratories?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Post the company results, investors will track FY27 guidance and growth strategies in the Specialty Pharma &#8211; API sector. Track live updates on the Univest Screener.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Where_can_I_track_Valiant_Laboratories_Q4_FY26_live_data\"><\/span><strong>Where can I track Valiant Laboratories Q4 FY26 live data?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Track the company live stock price, analyst ratings, and earnings updates on the Univest Screener for real-time investment data.<\/p>\n<p><em>Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. Consult a SEBI-registered advisor before making any investment decision.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Valiant Laboratories Q4 FY26 results: Valiant Laboratories Q4 FY26 results announced May 14, 2026. The company manufactures active pharmaceutical ingredients (APIs) for..<\/p>\n","protected":false},"author":26,"featured_media":88475,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-88135","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1778837858:26"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["77"],"rank_math_focus_keyword":["Valiant Laboratories Q4"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"rank_math_title":["Valiant Laboratories Q4 FY26: PAT Rs 0.70 Crore"],"rank_math_description":["Valiant Laboratories Q4 FY26 results: Valiant Laboratories Q4 FY26 results announced May 14, 2026. The company manufactures active pharmaceutical ingredients (APIs) for.."],"_thumbnail_id":["88475"],"_edit_last":["26"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["11651"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/05\/15145920\/Valiant-Laboratories-Q4-FY26-Results.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/88135","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=88135"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/88135\/revisions"}],"predecessor-version":[{"id":88477,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/88135\/revisions\/88477"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/88475"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=88135"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=88135"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=88135"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}